Xplore II

Protocol: 
AAAR 1862

Prospective, non-randomized, open label clinical study to assess the feasibility of the Bioabsorbable pulmonary valved conduit in subjects undergoing Right Ventricular Outflow Tract (RVOT) reconstruction

This is a multi-center prospective, single-arm, non-randomized, open label study to assess feasibility of the Xeltis Bioabsorbable Pulmonary Valved Conduit in subjects requiring Right Ventricular Outflow Tract correction or reconstruction due to congenital heart malformations.

Are you Eligible? (Inclusion Criteria)

  • 2-21 years of age
  • Patient requiring RVOT reconstruction, suitable for 16 mm or 18 mm valved conduit.
  • Male or female

Specialty Area(s)

Trial Location

Morgan Stanley Children's Hospital
3959 Broadway
Babies North, 2nd Floor
New York, NY 10032
United States